Dual Listed Biotech Begins to Prepare POC Preclinical Study for Diabetes & Obesity Dual Gene Therapy Program
December 04 2023 - 7:00AM
AllPennyStocks.com
Obesity and diabetes have become a problem for developed world
countries. To address the global rise of these issues, this company
is pursuing a dual-gene therapy strategy using
proprietary...
To read the full story on AllPennyStocks.com, click
here.
PreveCeutical Medical (QB) (USOTC:PRVCF)
Historical Stock Chart
From Apr 2024 to May 2024
PreveCeutical Medical (QB) (USOTC:PRVCF)
Historical Stock Chart
From May 2023 to May 2024
